Pertussis and pertussis vaccine: 1990
Mortimer, E.A.
Advances in Pediatric Infectious Diseases 5: 1-33
1990
ISSN/ISBN: 0884-9404 PMID: 2183817 Document Number: 352686
Document emailed within 1 workday
Related Documents
Shek, L.Pei.Chi.; Khor, E.Sek.Hoon.; Tan, G.Huat.; Low, K.Tzay.; Ong, D.; Roy, J.; Han, H.Htay.; Bock, H.Ludwig.; Lee, B.Wah. 2003: Comparative study of the reactogenicity of a three-component acellular pertussis vaccine and whole-cell pertussis vaccine administered to healthy Singaporean infants Southeast Asian Journal of Tropical Medicine and Public Health 34(4): 863-868Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579
Miura, S. 1968: Effects of the combined administration of a triple vaccine of pertussis, diphtheria and tetanus and virus vaccine (live polio vaccine or inactivated measles vaccine) on immunity to pertussis, diphtheria and tetanus. 1. Results of the initial immunization Nihon Shonika Gakkai Zasshi. Acta Paediatrica Japonica 72(6): 767-781
Schmitt-Grohé, S.; Stehr, K.; Cherry, J.D.; Heininger, U.; Uberall, M.A.; Laussucq, S.; Eckhardt, T. 1997: Minor adverse events in a comparative efficacy trial in Germany in infants receiving either the Lederle/Takeda acellular pertussis component DTP (DTaP) vaccine, the Lederle whole-cell component DTP (DTP) or DT vaccine. The Pertussis Vaccine Study Group Developments in Biological Standardization 89: 113-118
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Hinman, A.R.; Koplan, J.P. 1984: Pertussis and pertussis vaccine. Reanalysis of benefits, risks, and costs JAMA 251(23): 3109-3113
Schneerson, R.; Robbins, J.B.; Taranger, J.; Lagerård, T.; Trollfors, B. 1997: Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis Developments in Biological Standardization 89: 321-326
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Mills, K.H.; Brady, M.; Ryan, E.; Mahon, B.P. 1998: A respiratory challenge model for infection with Bordetella pertussis: application in the assessment of pertussis vaccine potency and in defining the mechanism of protective immunity Developments in Biological Standardization 95: 31-41
Frühwirth, M.; Wolf, H.; Heininger, H.; Guggenbichler, J.P.; Stehr, E. 1995: Secretory IgA against pertussis toxin and surface structures of Bordetella pertussis in saliva of children with culture proven pertussis Advances in Experimental Medicine and Biology 371b: 777-783
Chodorowska, M. 1999: Humoral reaction to Bordetella pertussis antigens: pertussis toxin, filamentous hemagglutinin and lipopolysaccharide in children with clinical symptoms of whooping cough. II. Occurence and level of B. pertussis antigens in children with suspected whooping cough Medycyna Doswiadczalna i Mikrobiologia 51(3-4): 269-280
Adonajlo, A.; Mazurowska-Magdzik, M.; Pstragowska, W.; Dadak, M. 1975: Effect of infectious diseases on levels of pertussis antibodies in children vaccinated against pertussis Przeglad Epidemiologiczny 29(3): 321-326
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Siundiukova, R.A.; Basnak'ian, I.A.; Stukalova, N.V.; Aleksakhina, N.N. 1999: The effect of methylated cyclodextrin on pertussis toxin accumulation in a Bordetella pertussis culture in a bioreactor Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 6: 14-17
Shahdadpuri, R.I.; Nicholson, A.J.; Bedford, D.; O'Flanagan, D. 2004: Pertussis--going, going, but not gone: thirteen year trends in the incidence of pertussis in the Republic of Ireland and North Eastern Health Board Irish Medical Journal 97(2): 44-46
Lau, R.C. 1989: Pertussis (whooping cough) toxin and Bordetella pertussis whole-cell antibody levels in a healthy New Zealand population New Zealand Medical Journal 102(878): 560-562
Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274
Wilhelmson, B. 1993: Trial and error for pertussis vaccine. Does the new recombinant vaccine have superior qualities? Lakartidningen 90(26-27): 2458-2459